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ABSTRACT 
Introductions: Juvenile idiopathic arthritis (JIA) is a heterogeneous 
group of disorders with different manifestations. There is lack of 
data locally. In this study, we describe the clinical profile and 
functional outcome of patients with JIA attending two rheumatology 
clinics in Lalitpur, Nepal.  
 
Methods: This cross sectional study wasconducted at Patan Hospital 
and Aarogya Health Home, Lalitpur, Kathmandu, Nepal. The medical 
records of patients with juvenile arthritis during the period between 
Jan 2013 to Dec 2015 were retrospectively reviewed for clinical 
profile and functional outcome of disease. 
 
Results: A total of 81 patients with arthritis diagnosed before age 16 
years were seen during this period. Seventy eight patients with JIA 
included 41 males and 37 females. Mean age of onset was 9.21 
years. Polyarticular JIA was seen 32 (42.2%), oligoarticular in 24 
(30.7%), enthesitis-related 13 (16.6%), and systemic-onset in 6 
(7.7%). Systemic complications were seen in 14 (17.9%) cases. Five 
cases had uveitis. Joint deformities were present in 28 (35.8%). Sixty 
seven (86%) children continued their education. Functional 
limitation (Steinbrocker’s functional class III and IV) was seen in 4 
(5.1%). One child with oligoarticular JIA died.  
 
Conclusions: The clinical profile of JIA in Nepalese patients is similar 
to studies from other parts of the World. During the short follow up, 
functional limitation was not a major problem.  
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INTRODUCTIONS 
 
Juvenile idiopathic arthritis (JIA) is an umbrella-
term describing a heterogeneous group of 
childhood conditions characterized by chronic 
arthritis beginning before the age of 16 years, 
persisting for at least 6 weeks, and having no 
other identifiable cause.1It is the most 
common rheumatic condition of childhood.2 
International League of Associations for 
Rheumatology (ILAR) has classified JIA into 
seven subtypes: systemic, oligoarticular, 
polyarticular rheumatoid factor (RF) positive 
and RF negative, enthesitis-related arthritis 
(ERA), psoriatic and “other” JIA.1It is an 
important cause of short and long term 
disability in children with decreased daily 
function and quality of life.2 
 
Epidemiologic studies have noted wide 
differences in occurrence of JIA among 
different populations.3There is lack of 
published data on the epidemiologic pattern 
and clinical characteristics of JIA locally. This 
study provides information on the clinical 
profile of JIA from two rheumatology clinics 





This was a cross sectional study conducted at 
Rheumatology Clinics of Patan Hospital and 
Aarogya Health Home, both located in Lalitpur 
district of Kathmnadu valley. Patan Hospital is 
a tertiary care teaching hospital of Patan 
Academy of Health Sciences (PAHS) whereas 
Aarogya Health Home is a private 
rheumatology clinic dedicated to the care of 
patients with rheumatic diseases. The medical 
records of children and youths diagnosed with 
JIA in the rheumatology service of these 
centres during the period between January 
2013 to December 2015 were retrospectively 
reviewed. Information about patient’s 
demography and clinical details on subtype of 
JIA, age of onset, involved joints, systemic 
symptoms, systemic complications and 
presence of deformities were extracted from 
patient’s clinical record sheet. Lab records 
included serological tests, RF, antinuclear 
antibody (ANA) and HLA B27. The ILAR criteria 
requires at least two positive RF assays to be 
done at least three months apart in the first six 
months of the disease in order to diagnose RF 
positive polyarthritis,1 due to cost factor only 
one positive or negative assay was considered 
sufficient to classify a patient with 
polyarthritis.  
 
The impact of disease on patients’ overall 
wellbeing was assessed by recording the 
Steinbrocker’s4 functional classes, continuation 
of education and mobility at last follow up. 
Steinbrocker’s functional class is the 
physician’s assessment of patients’ capacity to 
perform activities of daily living, either at 
home or at work (Class I: normal functional 
status, Class II: adequate for normal activities, 
Class III: limited duties or self-care, Class IV: 
bed- or wheel-chair ridden, incapacitating 
condition). The death at home or other health 
facility was confirmed and recorded. Arthritis 
with a known cause (e.g., Enteropathic 
arthritis) or arthritis diagnosed past the age of 
16 was excluded. Ethical approval was taken 
from Institutional Review Committee of PAHS. 





There were 81 JIA seen during the study 
period. Of these, three were excluded as 
diagnosis turned out to be different later (1 
Enteropathic arthritis secondary to Crohn’s 
disease, 1 Behcet’s disease, and 1 Henoch-
Schonleinpurpura). The remaining 78 JIA were 
analysed, male 41 and female 37, male to 
female ratio 1.1:1. Polyarticular JIA were 33 
(42.2%),21(26.9%) RF negative and 12(15.3%) 
RF positive. Oligoarticular JIA were 24(30.7%), 
ERA in 13(16.6%) and systemic onset JIA in 6 
(7.7%). Psoriatic and undifferentiated JIA were 




Systemic complications were seen in 14 
(17.9%) patients and were more frequent in 
polyarticular JIA. Growth disturbances which 
included leg length discrepancy was seen in 
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with longstanding RF positive polyarticular 
disease. Five (6.4%) had uveitis. One patient 
with RF positive polyarticular JIA had multiple 
complications: complete blindness due to 
bilateral uveitis and severe aortic 
regurgitation.  
 
Joint deformities were present in 28 (35.8%) 
patients. Fixed flexion deformity, deformity of 
elbow and button hole deformity were found 
in12 (15.4%), 5(6.4%) and 1(1.3%) respectively. 
Ten patients (12.8%) had multiple deformities 
in combination of fixed flexion deformities of 




RF was tested in all patients, ANA in 60 cases. 
The RF was positive in 12(15.4%), all in 
polyarticular disease. Among the tested ones, 
ANA was positive in 3(3.8%). The HLA B27 was 
done in 9 cases of ERA and 6 of these (66.7%) 
had this gene present. 
 
Impact of disease on patient’s wellbeing: 
functional outcome, education, mobility and 
death 
 
Impact of disease on patients’ overall 
wellbeing was assessed by Steinbrocker’s 
functional class, continuation of education and 
mobility recorded on last follow up. There 
were 71 (90.9%) class I, 3 (3.8%) class II and 4 
(5.1%) class III and nil in class IV.  Seventy five 
(96%) were mobile and 3 (4%) crutch users 
hadpolyarticular disease. There were 11 (14%) 
given up study due to various reasons related 
to the disease and remaining 86% were 
continuing their education. One child (1.3%) 





There was slight male dominance (53%) in our 
series similar to Indian5 and Turkish9studies. 
This is in contrary to the studies from Western 
countries7,8 with female predominance. The 
mean age in our series was 14.24 years, a little 
higher than other studies.5-8 This is most likely 
due to the fact that we included all patients 
with JIA irrespective of current age who had 
developed the disease before the age of 16 
years. 
 
If RF status is not taken into consideration, 
polyarticular disease was the most commonly 
observed form of JIA (altogether 42.2% of 
which26.9% were RF negative and 15.3% RF 
positive). However, oligoarticular JIA was the 
most frequent single entity observed. The 
distribution of all forms of JIA was more or less 
similar to the results from other studies.5-8 One 
striking difference from neighbouring Indian 
study5 was that RF negative polyarticular JIA 
and oligoarticular JIA were more common and 
ERA was less common in our series. Some of 
the children classified as RF negative 
polyarticular JIA may in reality be extended 
oligoarthritis as it was difficult to distinguish 
these two because of lack of routine follow ups 
and delay during the follow ups. Also we did 
not subdivide oligoarthritis into persistent and 
extended forms as it was not possible to do so 
due to the retrospective nature of the study.  
 
Due to limitation of resources, we obtained a 
single RF test to classify patients into RF 
positive or negative status, similar to other 
studies.5,6 This might have caused 
overrepresentation of RF positive polyarthritis 
patients in our series as a child with one 
positive assay was classified as RF positive 
polyarthritis without having a repeat test as 
suggested by ILAR. Only 3 (out of 60 tested), 
patients had positive ANA and all if these 
belonged to oligoarticular JIA. This low rate of 
ANA positivity as compared to western studies 
could be the fact that most of the laboratories 
in our setting use ELISA as opposed to standard 
immunofluorescence method for this test.10 
 
Systemic onset JIA was in similar frequency to 
studies from India and South Africa, though, 
much lesser than from Eastern Europe and 
Latin America.5-8 The ERA, though less than 
that in India and South Africa, was a significant 
observation in our study. Other studies have 
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There was one case each of psoriatic and 
undifferentiated arthritis in our series. 
Psoriatic arthritis is not a common rheumatic 
disease in Nepalese population.12 Our patient 
with psoriatic arthritis had family history of 
psoriasis in father. The small number of 
undifferentiated arthritis in our series could be 
due to small sample size. 
 
 










Number of Patients 78 235 78 668 397 
Current age (years) 14.24 ---- 12.4 11.4 10.7 
Age of onset (years) 9.21 12 7.3 6.8 6.6 
Male (%) 52.6% 58% 50% 28% 32% 
Polyarthritis  42.2% 29% 40.9% 33% 40.6% 
RF positive polyarthritis 15.3% 12% 14%   
RF negative polyarthritis 26.9% 17% 26.9%   
Oligoarthritis 30.7% 21% 26.8% 43.6% 30.9% 
Persistent oligoarthritis  17% 21.8% 31.6% 21.9% 
Extended oligoarthritis  4% 5% 12% 9% 
Systemic onset 7.7% 8% 7.69% 23% 28.5% 
ERA 16.6% 36% 23% --- --- 
Psoriatic arthritis  1.3% 1% 1.28% --- --- 
Undifferentiated 1.3% 5% 0% --- --- 
Note: JIA= Juvenile idiopathic arthritis , RF= rheumatoid factor, ERA=enthesitis-related arthritis 
 
Systemic complications, particularly for 
polyarticular JIA was a major problem seen in 
our study with leg length shortening. This is 
due to the involvement of the knee joint and is 
reported commonly with longstanding JIA.13 
Uveitis was seen in 6.4%, less common than 
14% reported from Germany.13 Uveitis was 
most frequently observed in patients with ERA. 
One of our patients with RF positive 
polyarticular JIA had complete blindness due 
to bilateral uveitis, a dreadful complication of 
JIA. Joint deformities, mostly in the form of 
flexion deformities,  were a common finding 
(35.8%) in our series, probably an effect of 
delayed initiation of treatment and lack of 
early physical therapy as children often 
develop flexion contractures if adequate 
physiotherapy is not instituted on time.  
 
Although majority of patients with JIA have 
good physical outcome when they reach 
adulthood, many patients may experience 
functional limitation owing to joint deformities 
and destruction, growth abnormalities and 
retardation and osteoporosis.14 Our patient 
follow up varied from few months to 2 years. 
During this follow up period, severe functional 
limitation (Steinbrocker’s functional class III 
and IV) was seen in 5.1% of patients which is a 
very low figure probably due to short follow 
up. Western studies have shown that in longer 
follow up for 10-15 years, 30-56% patients 
have this degree of limitation.14 Three patients 
with severe polyarticular disease in our series 
were crutch users. The high rate (86%) of 
continuation of education despite the 
debilitating nature of disease reflects that 
parents have given high priority for education. 
The unexpected death of one child with well 
controlled oligoarticular JIA doesn’t seem to be 
related to arthritis and may have some other 
cause. 
 
Small sample size and clinic-based data in this 
study may have skewed the results in several 
ways. Patients attending our rheumatology 
clinics were the ‘selected’ ones and may have 
more severe disease than those in the 
community. Thus milder forms of JIA may not 
have been the part of this study as they have 
higher chances of going into remission and do 
not present to the specialist clinics. Owing to 
this selection or referral bias, the information 
derived from the hospital based database like 
13  
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ours may exert some skewed impression on 
clinical characteristics (subtypes, complications 
and serological status) and functional outcome 
of the disease.  
 
Despite these limitations, this study fulfils the 
information gap on JIA from Nepal. More 
comprehensive research on larger sample size 





Polyarticular disease was the most common 
form of JIA, followed by oligoarticular, 
enthesitis-related and systemic-onset JIAs. 
Systemic complications were frequent in 
polyarticular JIA with fixed flexion deformities 
of elbows and knees. Severe functional 
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